Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

13.30
Delayed Data
As of Feb 05
 -0.75 / -5.34%
Today’s Change
12.82
Today|||52-Week Range
32.95
-29.89%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close14.05
Today’s open13.96
Day’s range13.25 - 13.96
Volume40,160
Average volume (3 months)59,152
Market cap$234.2M
Dividend yield5.02%
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+46.57%
Earnings growth (next 5 years)+545.30%
Revenue growth (last year)--
P/E ratioNM
Price/Sales22.45
Price/Book2.01

Competitors

 Today’s
change
Today’s
% change
BITIBiotie Therapies Oyj-0.61-2.39%
HSKAHeska Corp-0.17-0.46%
CHMAChiasma Inc-0.54-5.05%
LBIOLion Biotechnologies...-0.33-6.08%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 31, 2016
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$4.3M
Annual profit (last year)-$17.8M
Net profit margin-410.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers